FIELD: chemistry.
SUBSTANCE: invention relates to novel derivatives of formula (I), also to pharmaceutical compositions containing such compounds, to methods for preparing such compounds and compositions, to the use of such compounds or pharmaceutical compositions for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases. 
(I).
EFFECT: technical result: obtaining novel compounds which are inhibitors of the phosphodiesterase 10 (PDE10) enzyme and which may be useful for the treatment or prevention of neurological, psychiatric and metabolic disorders involving the PDE10 enzyme.
13 cl, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS COMPRISING PDE 2 INHIBITORS SUCH AS 1-ARYL-4-METHYL- [1,2,4]TRIAZOLO[4,3-A]QUINOXALINE COMPOUNDS AND PDE 10 INHIBITORS FOR USE IN TREATMENT OF NEUROLOGICAL OR METABOLIC DISORDERS | 2013 |
|
RU2657540C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2709786C2 |
| 1,2,4-TRIAZOLO[4,3-A]PYRIDINE COMPOUNDS AND USE THEREOF AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | 2015 |
|
RU2695651C2 |
| 6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZINE-4(5H)-ONE COMPOUNDS AND USE THEREOF AS NEGATIVE ALLOSTERIC MODULATORS OF mGluR2 RECEPTORS | 2015 |
|
RU2708391C2 |
| 6,7-DIHYDROPYRAZOLO[1,5-α]PYRAZIN-4(5H)-ONE COMPOUNDS AND USE THEREOF AS NEGATIVE ALLOSTERIC MODULATORS OF mGluR2 RECEPTORS | 2015 |
|
RU2696135C2 |
| HETEROARYLIC COMPOUNDS AND METHODS FOR THEIR APPLICATION | 2013 |
|
RU2644558C2 |
| 6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZINE-4(5H)-ONE COMPOUNDS AND USE THEREOF AS NEGATIVE ALLOSTERIC MODULATORS OF mGluR2 RECEPTORS | 2015 |
|
RU2711382C2 |
| CHROMON OXIME NEW DERIVATIVE AND ITS USE AS ALLOSTERIC MODULATOR OF METABOTROPIC GLUTAMATE RECEPTORS | 2015 |
|
RU2672569C2 |
| SUBSTITUTED NAPHTHYRIDINE AND QUINOLINE COMPOUNDS AS MAO INHIBITORS | 2014 |
|
RU2661156C2 |
| AMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR APPLICATION METHODS | 2017 |
|
RU2759913C2 |
